导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.25% | 707/1050 |
| 近一周 | -5.06% | 1072/1104 |
| 近一月 | 0.05% | 86/1102 |
| 近一季 | -0.79% | 282/1092 |
| 近半年 | -15.77% | 906/1070 |
| 近一年 | 22.99% | 211/1018 |
| 近两年 | 103.51% | 176/926 |
| 近三年 | 81.69% | 122/834 |
| 成立以来 | 454.07% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.85% 421/1070 |
-21.85% 1060/1101 |
- - |
- - |
| 2025 | 92.50% 18/1065 |
7.10% 276/1014 |
6.32% 223/1038 |
40.19% 191/1050 |
20.59% 6/1065 |
| 2024 | 9.67% 298/1011 |
16.88% 6/960 |
1.41% 221/983 |
5.05% 884/991 |
-11.92% 953/1011 |
| 2023 | -1.89% 132/952 |
5.26% 307/880 |
-6.13% 585/895 |
4.00% 6/915 |
-4.53% 456/952 |
| 2022 | -2.65% 27/867 |
-6.32% 46/773 |
8.31% 339/806 |
-2.00% 30/845 |
-2.09% 541/867 |
| 2021 | 10.49% 242/740 |
-0.22% 160/580 |
15.46% 228/659 |
4.11% 145/704 |
-7.88% 633/740 |
| 2020 | 74.50% 120/554 |
-14.04% 407/419 |
23.79% 214/466 |
23.76% 25/517 |
32.50% 34/554 |
| 2019 | 28.99% 295/410 |
9.78% 1055/1146 |
0.92% 241/1228 |
-0.66% 350/390 |
17.20% 28/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实资源精选股票C VS. 东吴新产业精选股票A(580008) |